Study | Diagnosis of CPPD | CPPD cohort size/ comparator cohort size | Primary disease studied | Design | QUADAS scale (/1 4) | Assessment comparator (imaging or other) |
---|---|---|---|---|---|---|
Foldes 19 | X-rays (Resnick) | 21/19 | CPPD/OA | P, C | 8.5 | X-ray |
Filippucci et al15 | McCarty criteria | 48/84 | CPPD/ORD | P, C | 12.5 | ND |
Filippou et al16 | CPPD synovial crystals | 15/28 | CPPD/OA | P, C | 12.5 | ND |
Ellabban et al17 | CPPD synovial crystals | 38/22 | CPPD/gout and HA | P, C | 12.5 | X-ray |
Falsetti et al18 | McCarty criteria | 57/100 | CPPD/OA+H | P, C | 10.5 | X-ray, CE |
Gutierrez et al20 | CPPD synovial crystals | 74/83 | CPPD/ORD | P, C | 13 | X-ray, CE |
Ellabban et al21 | McCarty criteria | 38/22 | CPPD/OA | P, C | 10.5 | X-ray, CE |
Filippou et al22 | CPPD meniscal crystals | 3/3 | CPPD/OA | P, C | 10 | Histology |
Frediani et al7 | CPPD synovial crystals | 11/13 | CPPD/OA | P, D | 11 | X-ray |
Contant et al23 | CPPD synovial crystals | 30/36 | CPPD/ORD | P, C | 13.5 | X-ray |
Juge et al24 | CPPD synovial crystals | 16/16 | CPPD/ORD | P, C | 13 | X-ray |
Catay et al26 | CPPD synovial crystals | 15/60 | CPPD/ORD | P, C | 13 | X-ray, CE |
Filippou et al8 | CPPD meniscal crystals | 3/3 | CPPD/OA | P, D | 13 | Histology |
Filippucci et al9 | McCarty criteria | 46/39 | CPPD/gout | P, D | 11 | CE |
Filippucci et al10 | McCarty criteria | 70/30 | CPPD/gout | P, D | 9.5 | CE |
Coari et al11 | McCarty criteria | 28/46 | CPPD/ND | P, D | 9.5 | X-ray |
Filippou et al12 | CPPD synovial crystals | 42/0 | CPPD | P, D | 11 | X-ray |
Grassi et al13 | CPPD synovial crystals | 34/26 | CPPD/gout | P, D | 8.5 | ND |
Filippou et al25 | CPPD meniscal crystals | 25/16 | CPPD/OA | P, C | 11.5 | Histology |
Ciapetti et al14 | CPPD synovial crystals | 42/0 | CPPD | P, D | 8.5 | ND |
Barskova et al5 | McCarty criteria | 25/0 | CPPD | P, C | 11 | X-ray, CT scan |
C, comparative; CE, clinical examination; CPPD, calcium pyrophosphate deposition; D, descriptive; H, healthy; HA, hydroxyapatite; ND, not defined; OA, osteoarthritis; ORD, other rheumatic disease; P, prospective.